Anti-apoptotic therapeutic approaches in liver diseases: do they really make sense?

Area of Science:

• Hepatology and cell death research.

Background:

• Apoptotic cell death was previously considered central to liver injury, prompting investigation into anti-apoptotic therapies.
• Clinical translation of anti-apoptotic strategies has been limited due to an overestimated role of apoptosis in liver injury.

Purpose of the Study:

• To accurately quantify apoptotic cell death in various hepatic stress models relevant to human pathophysiology.
• To reassess the therapeutic potential of anti-apoptotic strategies for liver injury.

Main Methods:

• Utilized morphological criteria, caspase-3 activation, and TUNEL assay to quantify apoptosis in parenchymal and non-parenchymal liver cells.
• Confirmed apoptosis levels through cleaved caspase-3 and PARP-1 protein expression.
• Employed relevant hepatic stress models mimicking human pathophysiology.

Main Results:

• Quantified apoptotic cell death across different liver injury models.
• Confirmed apoptosis levels using multiple validated assays and protein markers.
• Demonstrated variability in apoptosis extent depending on the specific hepatic stress model.

Conclusions:

• The role of apoptosis in liver injury may be overestimated, tempering the efficacy of anti-apoptotic strategies.
• Reconsidering anti-apoptotic strategies is recommended for efficient amelioration of liver injury.
• Further research is needed to refine therapeutic approaches for liver diseases.